Neuro Service Line

Neuro

PATHOLOGY

Ischemic Stroke & ICH

Vendor

Nanoxai

APP CINA (for ICH) CINA (for LVO)

DESCRIPTION

CINA is a computer aided triage and notification software which supports worklist prioritization by flagging and communicating suspected positive findings of Intracranial Hemorrhage (ICH) and large vessel occlusion (LVO).1

MODALITY
CT


CINA has CE marking and risk class I.

PATHOLOGY

Traumatic Brain Injury

Vendor

icometrix

APP icobrain ct & icobrain mr

DESCRIPTION

icobrain ct and mr support the interpretation of standardized and quantified brain scans for traumatic brain injuries by uncovering mass effects and diffuse consequences of brain damage.2,3

MODALITY
CT, MRI


icobrain ct and icobrain mr have CE marking (CE1639) and risk class Im.

PATHOLOGY

Neurodegenerative Disease

Vendor

icometrix

APP icobrain ct & icobrain mr

DESCRIPTION

icobrain ct and mr support the differential diagnosis of the most common dementia types. It uncovers abnormality patterns by quantifying and tracking the annualized brain volume changes of dementia-specific brain structures.2,3​

MODALITY
CT, MRI


icobrain ct and icobrain mr have CE marking (CE1639) and risk class Im.

PATHOLOGY

Multiple Sclerosis

Vendor

icometrix

APP icobrain mr

DESCRIPTION

icobrain mr supports assessment of brain lesion dissemination by detecting, quantifying, and tracking the evolution of FLAIR white matter hyperintensities, T1 white matter hypointensities and contrast-enhancing T1 hyperintensities to evaluate MS disease activity.2

MODALITY
MRI


icobrain mr has CE marking (CE1639) and risk class Im.

Not all offerings are available in all market. For availability specific to your country please contact your local Bayer representative.

  1. Instructions for Use CINA, software version 1.0
  2. Instructions for Use icobrain mr, software version 5.8
  3. Instructions for Use icobrain ct, software version 6.1

© 2023 Bayer

The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.

BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.

This is intended to provide information for healthcare professionals and other relevant decision makers in the European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.

 

The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://manuals.radiology.bayer.com/op-manuals

 

You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect

Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.

 

PP-CALA-ALL-0464-1 April 2023

Bayer Logo